Browsing Over 33 Sessions

Sort By
View

16 - Amgen - BiTE® therapy: The frontier in solid tumour immune-oncology

Time
17:00 - 18:00

21 - AstraZeneca - Immuno-oncology treatment paradigms for first-line ES SCLC and unresectable Stage III NSCLC: A case-based programme

Time
12:35 - 13:35
Channel 3 Special session

At the cutting edge of cancer immunotherapy – in collaboration with SITC

Date
12.12.2020
Time
12:35 - 13:55
Channel
Channel 3
Chairs
  • Solange Peters (Lausanne, Switzerland)
  • Tanja De Gruijl (Amsterdam, Netherlands)
Channel 2 Educational session

B-cell biology

Date
12.12.2020
Time
12:35 - 13:55
Channel
Channel 2
Chairs
  • Göran Jönsson (Lund, Sweden)
  • Brad Nelson (Victoria, BC, Canada)

9 - Bristol Myers Squibb - 2020 in Review: Recent Advances in Immuno-Oncology Combinations and Cellular Therapies

Time
12:35 - 13:35
Channel 3 Educational session

Compartmental biomarker analysis and the management of IO therapy

Date
12.12.2020
Time
11:00 - 12:20
Channel
Channel 3
Chairs
  • Tanja De Gruijl (Amsterdam, Netherlands)
  • Etienne Giroux-Leprieur (Boulogne-Billancourt, France)

28 - F. Hoffmann-La Roche Ltd. - Perspectives on the role of circulating tumour DNA

Time
17:00 - 18:00
Channel 1 Educational session

Future of adjuvant and neoadjuvant treatment

Date
10.12.2020
Time
11:00 - 12:20
Channel
Channel 1
Chairs
  • Christian U. Blank (Amsterdam, Netherlands)
  • Caroline Robert (Villejuif, France)
Channel 1 Educational session

I-O Highlights of 2020

Date
11.12.2020
Time
09:45 - 10:45
Channel
Channel 1
Chairs
  • John Haanen (Amsterdam, Netherlands)
Channel 2 Educational session

Identifying and targeting tumour antigens

Date
11.12.2020
Time
11:00 - 12:20
Channel
Channel 2
Chairs
  • Naiyer Rizvi (New York, NY, United States of America)
  • Marco Donia (, Denmark)
Channel 2 Educational session

Immune metabolic regulations

Date
10.12.2020
Time
13:50 - 15:10
Channel
Channel 2
Chairs
  • Per Thor Straten (Copenhagen, Denmark)
  • Michele Teng (Brisbane, Australia)
Channel 3 Educational session

Immuno-oncology in the context of other anticancer treatment

Date
10.12.2020
Time
13:50 - 15:10
Channel
Channel 3
Chairs
  • Marka Crittenden (Portland, OR, United States of America)
  • ALAN MELCHER (London, United Kingdom)